Proenkephalin, Neutrophil Gelatinase-Associated Lipocalin, and Estimated Glomerular Filtration Rates in Patients With Sepsis
2
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Background: Proenkephalin (PENK) has been suggested as a novel biomarker for kidney function. We investigated the diagnostic and prognostic utility of plasma PENK in comparison with neutrophil gelatinase-associated lipocalin (NGAL) and estimated glomerular filtration rates (eGFR) in septic patients. Methods: A total of 167 septic patients were enrolled: 99 with sepsis, 37 with septic shock, and 31 with suspected sepsis. PENK and NGAL concentrations were measured and GFR was estimated by using the isotope dilution mass spectrometry traceable-Modification of Diet in Renal Disease (MDRD) Study and three Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations: CKD-EPICr, CDK-EPICysC, and CKD-EPICr-CysC. The PENK, NGAL, and eGFR results were compared according to sepsis severity, presence or absence of acute kidney injury (AKI), and clinical outcomes. Results: The PENK, NGAL, and eGFR results were significantly associated with sepsis severity and differed significantly between patients with and without AKI only in the sepsis group (all P<0.05). PENK was superior to NGAL in predicting AKI (P=0.022) and renal replacement therapy (RRT) (P=0.0085). Regardless of the variable GFR category by the different eGFR equations, PENK showed constant and significant associations with all eGFR equations. Unlike NGAL, PENK was not influenced by inflammation and predicted the 30-day mortality. Conclusions: PENK is a highly sensitive and objective biomarker of AKI and RRT and is useful for prognosis prediction in septic patients. With its diagnostic robustness and predictive power for survival, PENK constitutes a promising biomarker in critical care settings including sepsis.
Abstract
Background: Proenkephalin (PENK) has been suggested as a novel biomarker for kidney function. We investigated the diagnostic and prognostic utility of plasma PENK in comparison with neutrophil gelatinase-associated lipocalin (NGAL) and estimated glomerular filtration rates (eGFR) in septic patients. Methods: A total of 167 septic patients were enrolled: 99 with sepsis, 37 with septic shock, and 31 with suspected sepsis. PENK and NGAL concentrations were measured and GFR was estimated by using the isotope dilution mass spectrometry traceable-Modification of Diet in Renal Disease (MDRD) Study and three Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations: CKD-EPICr, CDK-EPICysC, and CKD-EPICr-CysC. The PENK, NGAL, and eGFR results were compared according to sepsis severity, presence or absence of acute kidney injury (AKI), and clinical outcomes. Results: The PENK, NGAL, and eGFR results were significantly associated with sepsis severity and differed significantly between patients with and without AKI only in the sepsis group (all P<0.05). PENK was superior to NGAL in predicting AKI (P=0.022) and renal replacement therapy (RRT) (P=0.0085). Regardless of the variable GFR category by the different eGFR equations, PENK showed constant and significant associations with all eGFR equations. Unlike NGAL, PENK was not influenced by inflammation and predicted the 30-day mortality. Conclusions: PENK is a highly sensitive and objective biomarker of AKI and RRT and is useful for prognosis prediction in septic patients. With its diagnostic robustness and predictive power for survival, PENK constitutes a promising biomarker in critical care settings including sepsis.
참고문헌 (30)
- Singer M, "The third international consensus definitions for sepsis and septic shock (Sepsis-3)", JAMA, 315, pp.801~810 (2016)
- Lameire NH, "Acute kidney injury: an increasing global concern", Lancet, 382, pp.170~179 (2013)
- Rewa O, "Acute kidney injury-epidemiology, outcomes and economics", Nat Rev Nephrol, 10, pp.193~207 (2014)
- Honore PM, "Prevention and treatment of sepsis-induced acute kidney injury: an update", Ann Intensive Care, 5, pp.51~60 (2015)
- Alobaidi R, "Sepsis-associated acute kidney injury", Semin Nephrol, 35, pp.2~11 (2015)
- Ichai C, "Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)", Ann Intensive Care, 6, pp.48~ (2016)
- Ronco C, "Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective", Blood Purif, 37, pp.271~285 (2014)
- Zhang A, "Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis", Crit Care, 20, pp.41~ (2016)
- Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group", Ann Intern Med, 130, pp.461~470 (1999)
- Levey AS, "A new equation to estimate glomerular filtration rate", Ann Intern Med, 150, pp.604~612 (2009)
- Inker LA, "Estimating glomerular filtration rate from serum creatinine and cystatin C", N Engl J Med, 367, pp.20~29 (2012)
- Hoste EA, "Assessment of renal function in recently admitted critically ill patients with normal serum creatinine", Nephrol Dial Transplant, 20, pp.747~753 (2005)
- Shah KS, "Proenkephalin predicts acute kidney injury in cardiac surgery patients", Clin Nephrol, 83, pp.29~35 (2015)
- Marino R, "Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department", J Nephrol, 28, pp.717~724 (2015)
- Schulz CA, "High level of fasting plasma proenkephalin-A predicts deterioration of kidney function and incidence of CKD", J Am Soc Nephrol, 28, pp.291~303 (2017)
- Dellinger RP, "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012", Crit Care Med, 41, pp.580~637 (2013)
- The Kidney Disease Improving Global Outcomes (KDIGO) Working Group, "KDIGO clinical practice guideline for acute kidney injury", Kidney Int Suppl, 2, pp.1~138 (2012)
- Persson M, "Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke: a population-based cohort study from Malmö, Sweden", Atherosclerosis, 200, pp.191~198 (2008)
- Kidney Disease Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members, "KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease", Kidney Int Suppl, 3, pp.1~150 (2013)
- Muller MP, "Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?", Clin Infect Dis, 40, pp.1079~1086 (2005)
- McHugh ML, "Interrater reliability: the kappa statistic", Biochem Med (Zagreb), 22, pp.276~282 (2012)
- Zhu Y, "Comparisons between the 2012 new CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations and other four approved equations", PLoS One, 9, pp.e84688~ (2014)
- Ronco C, "Acute kidney injury: from clinical to molecular diagnosis", Crit Care, 20, pp.201~ (2016)
- Romanovsky A, "Pathophysiology and management of septic acute kidney injury", Pediatr Nephrol, 29, pp.1~12 (2014)
- Schrier RW, "Acute renal failure and sepsis", N Engl J Med, 351, pp.159~169 (2004)
- Gomez H, "A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaption to injury", Shock, 41, pp.3~11 (2014)
- Arbit B, "Prognostic usefulness of proenkephalin in stable ambulatory patients with heart failure", Am J Cardiol, 117, pp.1310~1314 (2016)
- Ng LL, "Proenkephalin and prognosis after acute myocardial infarction", J Am Coll Cardiol, 63, pp.280~289 (2014)
- Murray PT, "Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference", Kidney Int, 85, pp.513~521 (2014)
- Otto GP, "Plasma neutrophil gelatinase-associated lipocalin is primarily related to inflammation during sepsis: a translational approach", PLoS One, 10, pp.e0124429~ (2015)